18 research outputs found

    Effects of management practices on the ground beetle assemblages of grassland and related habitats (Coleoptera: Carabidae)

    Get PDF
    In a comparison of grassland, moorland and woodland habitats in north-east England, moorland sites were found to be the most diverse and species-rich and to support a carabid fauna of larger body size than grassland sites. Within the grassland sites, intensification of management resulted in a reduction both in species richness and in body size. The species composition of intensively managed sites differed from that of the less intensive, with management appearing to favour species associated with drier conditions. Similarly, a study of data from 110 sets of pitfall traps in managed and unmanaged grassland in Scotland found a general reduction in diversity, rarity and body size as management intensified, with silage fields having especially low values of WML. Diversity and rarity fell sharply between the second and third levels of management. Multivariate analysis of the species composition also made a clear distinction between these levels, grouping sites in bands 1 and 2 separately from those in bands 3 to 5. A more detailed examination of the effects of the different components of management found that body size was dependent mostly on the type and age of the sward, while diversity and rarity responded to nutrient inputs. In a subset of 36 of the 110 Scottish sites, the carabid assemblages of sown wildflower swards, sown grass and clover, and uncultivated grassland were compared. Body size, species richness and diversity were all highest in the unmanaged swards, and species richness and diversity were higher in wildflower swards than in sown grasses. The effects of organic nutrient input were investigated at sites receiving input of slurry, sewage sludge or faecal material from flocks of grazing geese, but not significant relationships could be elucidated due to overwhelming effects of sward type and management intensity

    Two novel flight-interception trap designs for low-cost forest insect surveys

    Get PDF
    This paper introduces two passive trap designs for the survey of flying Coleoptera and other insects which can be constructed on very low budgets at < £1 per trap. A trunk window trap and an aerial flight-interception trap are presented, based on commonly used designs, but using much cheaper materials than standard. Construction diagrams are given, along with a description of trap installation, operation and beetle species found using these methods during a survey of Ayr Gorge Woodland, South-West Scotland. The traps were found to be robust and easy to operate. It is hoped that these trap designs will be of use to charitable organisations, students and amateurs who may previously have been unable to consider monitoring flying insects at large scales due to the prohibitive cost of equipment

    Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets

    Get PDF
    Chronic obstructive pulmonary disease (COPD) is characterized by reduced lung function and is the third leading cause of death globally. Through genome-wide association discovery in 48,943 individuals, selected from extremes of the lung function distribution in UK Biobank, and follow-up in 95,375 individuals, we increased the yield of independent signals for lung function from 54 to 97. A genetic risk score was associated with COPD susceptibility (odds ratio per 1 s.d. of the risk score (∼6 alleles) (95% confidence interval) = 1.24 (1.20-1.27), P = 5.05 × 10‾⁴⁹), and we observed a 3.7-fold difference in COPD risk between individuals in the highest and lowest genetic risk score deciles in UK Biobank. The 97 signals show enrichment in genes for development, elastic fibers and epigenetic regulation pathways. We highlight targets for drugs and compounds in development for COPD and asthma (genes in the inositol phosphate metabolism pathway and CHRM3) and describe targets for potential drug repositioning from other clinical indications.This work was funded by a Medical Research Council (MRC) strategic award to M.D.T., I.P.H., D.S. and L.V.W. (MC_PC_12010). This research has been conducted using the UK Biobank Resource under application 648. This article presents independent research funded partially by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the UK Department of Health. This research used the ALICE and SPECTRE High-Performance Computing Facilities at the University of Leicester. Additional acknowledgments and funding details can be found in the Supplementary Note

    COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

    Get PDF
    Background: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results: ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≤ 18 years: 69, 48, 23; 85%), older adults (≥ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. Interpretation: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men

    Two novel flight-interception trap designs for low-cost forest insect surveys

    No full text
    This paper introduces two passive trap designs for the survey of flying Coleoptera and other insects which can be constructed on very low budgets at < £1 per trap. A trunk window trap and an aerial flight-interception trap are presented, based on commonly used designs, but using much cheaper materials than standard. Construction diagrams are given, along with a description of trap installation, operation and beetle species found using these methods during a survey of Ayr Gorge Woodland, South-West Scotland. The traps were found to be robust and easy to operate. It is hoped that these trap designs will be of use to charitable organisations, students and amateurs who may previously have been unable to consider monitoring flying insects at large scales due to the prohibitive cost of equipment

    Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

    No full text
    Background: Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (IMV). We aimed to describe the clinical characteristics, outcomes and risk factors for failing non-invasive respiratory support in patients treated with severe COVID-19 during the first two years of the pandemic in high-income countries (HICs) and low middle-income countries (LMICs). Methods: This is a multinational, multicentre, prospective cohort study embedded in the ISARIC-WHO COVID-19 Clinical Characterisation Protocol. Patients with laboratory-confirmed SARS-CoV-2 infection who required hospital admission were recruited prospectively. Patients treated with HFNC, NIV, or IMV within the first 24 h of hospital admission were included in this study. Descriptive statistics, random forest, and logistic regression analyses were used to describe clinical characteristics and compare clinical outcomes among patients treated with the different types of advanced respiratory support. Results: A total of 66,565 patients were included in this study. Overall, 82.6% of patients were treated in HIC, and 40.6% were admitted to the hospital during the first pandemic wave. During the first 24 h after hospital admission, patients in HICs were more frequently treated with HFNC (48.0%), followed by NIV (38.6%) and IMV (13.4%). In contrast, patients admitted in lower- and middle-income countries (LMICs) were less frequently treated with HFNC (16.1%) and the majority received IMV (59.1%). The failure rate of non-invasive respiratory support (i.e. HFNC or NIV) was 15.5%, of which 71.2% were from HIC and 28.8% from LMIC. The variables most strongly associated with non-invasive ventilation failure, defined as progression to IMV, were high leukocyte counts at hospital admission (OR [95%CI]; 5.86 [4.83-7.10]), treatment in an LMIC (OR [95%CI]; 2.04 [1.97-2.11]), and tachypnoea at hospital admission (OR [95%CI]; 1.16 [1.14-1.18]). Patients who failed HFNC/NIV had a higher 28-day fatality ratio (OR [95%CI]; 1.27 [1.25-1.30]). Conclusions: In the present international cohort, the most frequently used advanced respiratory support was the HFNC. However, IMV was used more often in LMIC. Higher leucocyte count, tachypnoea, and treatment in LMIC were risk factors for HFNC/NIV failure. HFNC/NIV failure was related to worse clinical outcomes, such as 28-day mortality. Trial registration This is a prospective observational study; therefore, no health care interventions were applied to participants, and trial registration is not applicable
    corecore